Project description
Finding ways to access, use and reuse patient data
Has the EU General Data Protection Regulation (GDPR) limited Europe’s capabilities in innovative drug development? The EU-funded FACILITATE project will explore the issue. Its aim is to find an ethical and GDPR-compliant framework for returning clinical trial data to study participants. Specifically, it will look for ways to allow patients’ data to be accessed, used and reused. The project will also show how a patient-centred data-driven approach can improve the drug development and approval process. The findings will shed new light on future strategies and opportunities for medicines development and regulation.
Objective
FACILITATE is a project built on a patient-centered, data-driven, technological platform where an innovative data sharing and re-use process allows the returning of clinical trial data to study participants within a GDPR compliant and approved ethical framework. FACILITATE starts-off by providing clear rules in a trusted ethical, legal and regulatory ecosystem before engaging patients as data generators. This avoids the current situation where clinical data are siloed in separate repositories without any possibility to be used beyond their original single-sided purpose. FACILITATE will provide the technological solutions to comply with GDPR in medical research by building on the empowered stakeholders' willingness to share and re-use their data. The FACILITATE Consortium was constituted by drawing from a broad range of capacities to tackle the ambitious challenges related to future clinical trials, such as preventive, long-term and real-world evidence trials. The Consortium took an innovative approach to the data return to study participants by asking them what they needed to be implemented to feel in a trusted ecosystem. This required all Consortium participants to leverage on their existing networks to bring together stakeholders at all levels in the decision-making chain, including patients, healthcare professionals, software designers, clinical trials repositories processors and controllers, ethicists, lawyers and other active regulators. Having obtained a consent on the data portability FACILITATE will re-use and cross-reference them with those contained in other repositories including RWE data captured across multiple settings and devices. FACILITATE will last 4 years and will participate in the extended Pilot on Open Research Data of Horizon 2020. Its strategy represents a unique and innovative opportunity for medicines drug development and regulation to better understand the clinics of diseases, and to evaluate the effectiveness of products in the healthcare system.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
41121 Modena
Italy
See on map
Participants (31)
1050 Bruxelles / Brussel
See on map
33100 Tampere
See on map
Participation ended
3584 BK Utrecht
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
00165 Roma
See on map
00183 ROMA
See on map
75008 Paris
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
186 00 Praha
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
26101 PANCEVO
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
6883 Novazzano
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
09010 Pula
See on map
33600 PESSAC
See on map
41124 Modena
See on map
8010 Graz
See on map
31-007 Krakow
See on map
11129 Belgrade
See on map
020125 Bucuresti
See on map
48599 Gronau
See on map
39100 Bolzano
See on map
75014 Paris
See on map
94250 GENTILLY
See on map
W6 7AP London
See on map
60064 North Chicago Il
See on map
151 85 Sodertaelje
See on map
51373 Leverkusen
See on map
CT13 9NJ Sandwich
See on map
8152 Glattpark
See on map
08022 Barcelona
See on map
91190 GIF-SUR-YVETTE
See on map
00165 Roma
See on map
10154 New York
See on map
4070 Basel
See on map